Health and Quality of Life of ITMO University's Students, Faculty and Staff

Quality of Life Clinical Trial

Official title:

Selected Health and Quality of Life Indicators Among ITMO University Students, Faculty and Staff

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05394441
• Other study ID #: 922022/4.3.1
• Status: Completed
• Start date: June 2, 2022
• Est. completion date: December 31, 2023

Study information

• Verified date: March 2024
• Source: ITMO University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study assess various indicators of physical and mental health, quality of life, well-being and satisfaction among students, faculty and staff of ITMO University. Participants are invited to join the study via informational web-site. Several quality of life indicators are obtained via surveys and some blood samples are taken to assess health condition.

Description:

Students, faculty and staff from ITMO University are invited to participate in health examination on the campus. Surveys, such as EQ-5D-5L, K10+OHQ29, PSQI and others, assess different aspects of quality of life related to health. Also participants are asked to undergo several measurements by the interviewer (waist, hips, height, weight and others). Moreover blood samples are taken from the participants and lipidogram, cholesterol and glycohemoglobin are checked.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 830
• Est. completion date: December 31, 2023
• Est. primary completion date: March 31, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• student, faculty or staff from ITMO University
• participants, who signed informed consent and consent for data gathering
• participants, who signed consent to enroll in following surveys and health check-ups

Exclusion Criteria:

• participants younger than 16 years old
• participants with acute conditions distorting quality of life assessment
• participants, who did not sign informed consent and consent for data gathering - participants, who did not sign consent to enroll in following surveys and health check-ups

Related Conditions & MeSH terms

• Quality of Life

Locations

Country	Name	City	State
Russian Federation	ITMO University	Saint Petersburg

Sponsors (1)

Lead Sponsor	Collaborator
ITMO University

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cholesterol	Measured by A15 biochemical automatic analyzer (Biosystem, Spain)	30 days
Primary	Lipidogram	Measured by A15 biochemical automatic analyzer (Biosystem, Spain)	30 days
Primary	Glycohemoglobin	Measured by Architect c8000	30 days
Primary	Distress	Global measure of distress based on questions about anxiety and depressive symptoms that a person has experienced in the most recent 4 week period measured by Kessler-10 questionnaire	30 days
Primary	Psychological well-being	Measured by Oxford Happiness Questionnaire (OHQ)	30 days
Primary	Health status and quality of life	Measured by EuroQOL-5 Dimension Questionnaire (EQ-5D-5L)	30 days
Primary	Nicotine dependence	Nicotine dependence across all nicotine product types including cigarettes and electronic cigarettes measured by The Penn State Nicotine Dependence Index	30 days
Primary	Diabetes risk score	The 10-year risk of type 2 diabetes mellitus (DM), including asymptomatic diabetes mellitus and impaired glucose tolerance (IGT) measured by The Finnish Diabetes Risk Score	30 days
Primary	Sleep quality and disturbances.	Measured by Pittsburgh Sleep Quality Index	30 days
Primary	Physical activity	The types of intensity of physical activity and sitting time that people do as part of their daily lives measured by International Physical Activity Questionnaire - Short Form	30 days
Primary	Emotional eating, external eating, and restrained eating behavior	Qualitative and quantitative assessment of eating disorders associated with overeating and accompanying obesity measured by Dutch Eating Behavior Questionnaire	30 days
Primary	Alcohol use	Problematic alcohol use, including possible alcohol use disorders measured by The Russian version of the Alcohol Use Disorders Identification Test (AUDIT)	30 days
Primary	Ischemic heart disease prediction	Measured by The Rose angina screening questionnaire	30 days
Primary	Retinopathy	Measured with non-mydriatic fundus camera	30 days
Primary	Ocular fundus condition	Measured with non-mydriatic fundus camera	30 days